NFKB1 and prostate carcinoma: Interestingly, inhibition of NF-κB activity was abolished in the presence of the actin-disrupting drug cytochalasin B confirming the recently postulated regulatory role of actin reorganization in mAR-induced apoptosis in prostate cancer cells [17].